BRAIN Biotech
its BRAINBiocatalysts segment supplies enzymes, microorganisms and ingredients for industrial use alongside CRO activity and production-strain development, and it holds a granted European patent (EP4301852 B1) for the CRISPR-BMC nuclease. The nuclease is active across prokaryotic and eukaryotic organisms — bacteria,…
- Country
- Germany
Commercial
BMC Nuclease (EP4301852 B1)
Coverage
| CN | EU | US | |
|---|---|---|---|
| crop-biotech | ✓ | ✓ | ✓ |
Regulatorsepa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Strain engineering (synbio CRO) | crop-biotech | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.